Genmab A/S ROE Ratio 2011-2026 | GMAB

Annual ROE Ratio Genmab A/S

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	24.88	15.42	18.37	17.59	24.59	21.9	14.82	17.04	-127.12	-

All numbers in DKK currency

Indicator range from annual reports

Maximum	Minimum	Average
24.88	-127.12	3.05

Quarterly ROE Ratio Genmab A/S

2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	1.51	3.02	3.02	1.51	20.41	37.8	37.8	18.9	19.93	2.05	2.05	1.03	4.82	7.59	7.59	3.8	3.8	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in DKK currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
37.8	1.03	10.39

ROE Ratio of other stocks in the Biotechnology industry

Issuer	ROE Ratio	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	15.76	-	2.43 %	$ 254 M	Germany
AgeX Therapeutics AGE	51843.24	-	-10.17 %	$ 12.2 K	USA
I-Mab IMAB	-85.31	-	-	$ 866 M	China
Midatech Pharma plc MTP	-330.29	-	-18.52 %	$ 27.3 M	Britain
Alexion Pharmaceuticals, Inc. ALXN	5.18	-	-	$ 40.3 B	USA
Biophytis SA BPTS	-751.94	-	-13.47 %	$ 169 M	France
Genfit SA GNFT	626.29	-	2.54 %	$ 160 B	France
EyeGate Pharmaceuticals, Inc. EYEG	-115.61	-	-1.52 %	$ 24.7 M	USA
Esperion Therapeutics ESPR	7.51	$ 3.13	0.16 %	$ 651 M	USA
Exelixis EXEL	36.21	$ 46.2	4.01 %	$ 12.5 B	USA
Athira Pharma ATHA	-380.03	-	-	$ 269 M	USA
Fortress Biotech FBIO	13.66	$ 2.49	1.22 %	$ 69.5 M	USA
Fennec Pharmaceuticals FENC	-27.46	$ 6.85	1.93 %	$ 196 M	USA
Galectin Therapeutics GALT	24.11	$ 2.28	2.24 %	$ 146 M	USA
Galapagos NV GLPG	-11.44	$ 28.82	1.51 %	$ 2.69 B	Belgium
Grifols, S.A. GRFS	9.2	$ 8.4	1.51 %	$ 6.83 B	Spain
Genprex GNPX	-203.83	$ 0.89	0.28 %	$ 830 K	USA
BioNTech SE BNTX	1.11	$ 94.21	-1.35 %	$ 27.2 B	Germany
InflaRx N.V. IFRX	-43.64	$ 2.37	20.05 %	$ 152 M	Germany
Immuron Limited IMRN	-12.31	$ 0.82	3.97 %	$ 6.82 M	Australia
Институт стволовых клеток человека ISKJ	17.55	-	-	-	Russia
Checkmate Pharmaceuticals CMPI	-88.4	-	-	$ 231 M	USA
Ionis Pharmaceuticals IONS	-46.9	$ 76.34	1.45 %	$ 12.2 B	USA
Innate Pharma S.A. IPHA	-41.02	$ 1.49	3.83 %	$ 235 M	France
INmune Bio INMB	-195.26	$ 1.51	-1.95 %	$ 37.4 M	USA
Kamada Ltd. KMDA	9.59	$ 8.31	1.22 %	$ 260 M	Israel
Kymera Therapeutics KYMR	-19.71	$ 85.92	3.88 %	$ 7.26 B	USA
Kazia Therapeutics Limited KZIA	-132.24	$ 12.98	-3.53 %	$ 1.72 B	Australia
ACADIA Pharmaceuticals ACAD	30.9	$ 23.02	2.98 %	$ 3.81 B	USA
Liquidia Corporation LQDA	-154.03	$ 41.73	3.97 %	$ 3.59 B	USA
Advaxis ADXS	196.88	-	-9.65 %	$ 45.9 M	USA
Can-Fite BioPharma Ltd. CANF	-175.75	$ 3.56	1.71 %	$ 5.86 M	Israel
Aeterna Zentaris AEZS	-401.79	-	5.93 %	$ 314 M	Canada
Aeglea BioTherapeutics AGLE	-21.7	-	-	$ 1.01 B	USA
Mirum Pharmaceuticals MIRM	-7.42	$ 106.77	0.9 %	$ 5.36 B	USA
CureVac N.V. CVAC	-59.8	-	-	$ 867 M	Germany
Applied Genetic Technologies Corporation AGTC	-62.37	-	-	$ 26.5 M	USA
MannKind Corporation MNKD	-11.49	$ 3.88	35.49 %	$ 1.19 B	USA
AIkido Pharma AIKI	-32.34	-	1.93 %	$ 17.4 M	USA
Mereo BioPharma Group plc MREO	1092.97	$ 0.27	-3.84 %	$ 660 M	Britain
Akero Therapeutics AKRO	-33.6	-	-	$ 3.67 B	USA
Aptose Biosciences APTO	93.75	-	-45.71 %	$ 1.2 M	Canada
Aptinyx APTX	-169.38	-	-39.0 %	$ 4.57 M	USA
Akouos AKUS	-37.09	-	0.23 %	$ 488 M	USA
Albireo Pharma ALBO	-19.38	-	-0.23 %	$ 916 M	USA
Allakos ALLK	-110.0	-	-	$ 28.6 M	USA
AlloVir ALVR	-55.11	-	4.14 %	$ 49.1 M	USA
Arcutis Biotherapeutics ARQT	-8.52	$ 23.63	0.9 %	$ 3.01 B	USA
Nanobiotix S.A. NBTX	-47.67	$ 39.36	13.2 %	$ 286 B	France
Allena Pharmaceuticals ALNA	-257.91	-	3.16 %	$ 1.9 M	USA